logo
KCAS Bio Unlocks Thousands of Citations With Author-Based Filtering Powered by Bioz

KCAS Bio Unlocks Thousands of Citations With Author-Based Filtering Powered by Bioz

Yahoo26-03-2025

PALO ALTO, CALIFORNIA / / March 26, 2025 / Bioz, Inc., the leader in citation management, is highlighting its partnership with KCAS Bio, a trusted provider of bioanalytical and biomarker services. Through the integration of a Bioz Content Hub, KCAS Bio is making it easier for researchers and industry professionals to explore a curated collection of peer-reviewed publications featuring key scientific contributors.
Unlike traditional citation tools, the Bioz Content Hub on KCAS Bio's website brings together relevant studies authored by KCAS Bio's experts, offering deeper insights into the scientific impact of KCAS Bio's services across the industry. End users can sift through over 14,000 citations, filtering results by journal, author, and technique to find the most relevant reference material for their projects. Additionally, users have the unique ability to specifically browse Ph.D. theses, giving them access to in-depth research and novel findings that may not be available in standard journal publications. The user-friendly interface, complete with a clean design and rounded-edge elements, allows visitors to seamlessly browse publications, access full citations, and engage with the latest in thought-leadership regarding bioanalytical and biomarker development.
Jason Hannah, Head of Marketing at KCAS Bio, shared his thoughts on the collaboration: "Partnering with Bioz has given us a fresh, data-driven way to highlight the depth of knowledge from our experts at KCAS Bio. We've been particularly pleased with how much time users are spending on our Content Hub-it's clear that researchers, sponsors and industry professionals value this resource. The ability to showcase scientific contributions from key authors in an intuitive and engaging way has been a great addition to our digital strategy."
By leveraging the Bioz platform, KCAS Bio gains a deeper understanding of visitor engagement, helping to refine their content strategy and strengthen connections with the scientific community.
"KCAS Bio is a great example of how service providers can use Bioz technology to highlight scientific impact," said Dr. Karin Lachmi, Chief Revenue Officer and Co-Founder of Bioz. "Their focus on author-driven content makes their Content Hub unique, providing industry professionals with a streamlined way to explore relevant publications."
As the partnership evolves, Bioz and KCAS Bio remain committed to scientific transparency and innovation, ensuring easy access to the data that helps drive drug discovery and development forward.
About BiozBioz is the world's most advanced AI search engine for scientific research, offering evidence-based product ratings and recommendations to guide scientists toward the most validated products for their discoveries. Bioz's solutions for suppliers include Bioz Badges and Content Hubs, web-based widgets that enhance user engagement and increase sales conversion.
About KCAS Bio
KCAS Bio is a premier international provider of bioanalytical and laboratory services that provides comprehensive GLP- and GCP-compliant development services from early discovery support through commercial approval and beyond. One of only a select few CROs offering both large and small molecule development with extensive capabilities and expertise, KCAS Bio provides a truly differentiated approach to its clients who are looking for both scientific expertise and excellent customer service. KCAS Bio is headquartered in the Kansas City, KS metro area, with locations in Philadelphia, PA and Lyon, France.
Helpful Links
Bioz
Bioz Badges
Bioz Stars
KCAS Bio
For more information on Bioz solutions for suppliers, please reach out to info@bioz.com.
Contact Information
Daniel Levitt CEOpr@bioz.com
SOURCE: Bioz, Inc.
View the original press release on ACCESS Newswire

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Warren officials considering forming Joint Economic District with nearby township
Warren officials considering forming Joint Economic District with nearby township

Yahoo

time23 minutes ago

  • Yahoo

Warren officials considering forming Joint Economic District with nearby township

WARREN, Ohio (WKBN) — The City of Warren is exploring a new way to boost economic development by partnering with a nearby township to create a Joint Economic District. The move could pave the way for major improvements in the area, all with an eye toward a major player — Kimberly-Clark, which announced it will build a manufacturing plant in Warren last month. Ohio Laws allow municipalities and townships to join forces and identify prime property for development and even tax themselves to fund improvements. In Warren's case, the city would serve as the municipal partner, supplying water and sewer services, while the district itself would do things like road work, powerline relocations and building new access roads for truck traffic. 'The JED is obviously a creature of statute, and it allows for municipalities and neighboring townships or township to work together where one has something and the other lacks it, and you kind of come together for this purpose,' said Warren Law Director Enzo Cantalamessa. City officials say Kimberly-Clark expects the project to take two to two-and-a-half years to complete, making the partnership a key step in delivering the infrastructure and services necessary for the company's expansion. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

MO State Rep. introduces bill to cut childhood poverty in half
MO State Rep. introduces bill to cut childhood poverty in half

Yahoo

time38 minutes ago

  • Yahoo

MO State Rep. introduces bill to cut childhood poverty in half

KANSAS CITY, Mo. — Missouri State Representative, Ray Reed announced Monday a bill that seeks to cut childhood poverty in half for Missouri children. During a Missouri General Assembly special session, Reed introduced the 'Missouri Child Tax Credit' bill in hopes for the state to invest in Missouri's low-income and working-class families. Potential Royals move to Kansas sparks mixed reaction in Overland Park 'At a time when we're considering investing nearly a billion dollars to retain a football team, I believe we must also ask ourselves what kind of state we want to be. If we have the resources to build stadiums, we have the resources to build stronger futures for Missouri's kids,' Rep. Reed, said. The statement comes on the same day Jackson County legislators approved the 2025 Jackson County budget, which included investments in community needs such affordable housing and health equity, according to Jackson County Executive Frank White Jr. The child tax credit seeks to provide direct payments to low-income families with children under the age of 18-years-old. Kansas City's Country Club Plaza struggles with closures and empty shops In a release form Reed's office, it states the bill is modeled after the 2021 Biden-Harris expansion that lifted more than three million children out of poverty nationwide. 'This bill isn't just about alleviating poverty—it's about unlocking potential,' Reed said. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Estimating The Fair Value Of Life360, Inc. (ASX:360)
Estimating The Fair Value Of Life360, Inc. (ASX:360)

Yahoo

timean hour ago

  • Yahoo

Estimating The Fair Value Of Life360, Inc. (ASX:360)

Life360's estimated fair value is AU$30.82 based on 2 Stage Free Cash Flow to Equity With AU$33.25 share price, Life360 appears to be trading close to its estimated fair value Our fair value estimate is 4.8% higher than Life360's analyst price target of US$29.42 How far off is Life360, Inc. (ASX:360) from its intrinsic value? Using the most recent financial data, we'll take a look at whether the stock is fairly priced by taking the expected future cash flows and discounting them to their present value. One way to achieve this is by employing the Discounted Cash Flow (DCF) model. It may sound complicated, but actually it is quite simple! We would caution that there are many ways of valuing a company and, like the DCF, each technique has advantages and disadvantages in certain scenarios. If you want to learn more about discounted cash flow, the rationale behind this calculation can be read in detail in the Simply Wall St analysis model. This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. We are going to use a two-stage DCF model, which, as the name states, takes into account two stages of growth. The first stage is generally a higher growth period which levels off heading towards the terminal value, captured in the second 'steady growth' period. In the first stage we need to estimate the cash flows to the business over the next ten years. Where possible we use analyst estimates, but when these aren't available we extrapolate the previous free cash flow (FCF) from the last estimate or reported value. We assume companies with shrinking free cash flow will slow their rate of shrinkage, and that companies with growing free cash flow will see their growth rate slow, over this period. We do this to reflect that growth tends to slow more in the early years than it does in later years. Generally we assume that a dollar today is more valuable than a dollar in the future, so we discount the value of these future cash flows to their estimated value in today's dollars: 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034 Levered FCF ($, Millions) US$58.8m US$84.5m US$143.6m US$175.0m US$216.0m US$247.1m US$274.2m US$297.7m US$318.1m US$336.3m Growth Rate Estimate Source Analyst x3 Analyst x3 Analyst x3 Analyst x1 Analyst x1 Est @ 14.40% Est @ 10.96% Est @ 8.56% Est @ 6.88% Est @ 5.70% Present Value ($, Millions) Discounted @ 7.9% US$54.5 US$72.6 US$114 US$129 US$148 US$157 US$161 US$163 US$161 US$158 ("Est" = FCF growth rate estimated by Simply Wall St)Present Value of 10-year Cash Flow (PVCF) = US$1.3b After calculating the present value of future cash flows in the initial 10-year period, we need to calculate the Terminal Value, which accounts for all future cash flows beyond the first stage. The Gordon Growth formula is used to calculate Terminal Value at a future annual growth rate equal to the 5-year average of the 10-year government bond yield of 2.9%. We discount the terminal cash flows to today's value at a cost of equity of 7.9%. Terminal Value (TV)= FCF2034 × (1 + g) ÷ (r – g) = US$336m× (1 + 2.9%) ÷ (7.9%– 2.9%) = US$7.1b Present Value of Terminal Value (PVTV)= TV / (1 + r)10= US$7.1b÷ ( 1 + 7.9%)10= US$3.3b The total value, or equity value, is then the sum of the present value of the future cash flows, which in this case is US$4.6b. To get the intrinsic value per share, we divide this by the total number of shares outstanding. Compared to the current share price of AU$33.3, the company appears around fair value at the time of writing. Remember though, that this is just an approximate valuation, and like any complex formula - garbage in, garbage out. We would point out that the most important inputs to a discounted cash flow are the discount rate and of course the actual cash flows. Part of investing is coming up with your own evaluation of a company's future performance, so try the calculation yourself and check your own assumptions. The DCF also does not consider the possible cyclicality of an industry, or a company's future capital requirements, so it does not give a full picture of a company's potential performance. Given that we are looking at Life360 as potential shareholders, the cost of equity is used as the discount rate, rather than the cost of capital (or weighted average cost of capital, WACC) which accounts for debt. In this calculation we've used 7.9%, which is based on a levered beta of 1.133. Beta is a measure of a stock's volatility, compared to the market as a whole. We get our beta from the industry average beta of globally comparable companies, with an imposed limit between 0.8 and 2.0, which is a reasonable range for a stable business. View our latest analysis for Life360 Strength Currently debt free. Weakness No major weaknesses identified for 360. Opportunity Annual earnings are forecast to grow faster than the Australian market. Good value based on P/S ratio compared to estimated Fair P/S ratio. Threat Revenue is forecast to grow slower than 20% per year. Although the valuation of a company is important, it shouldn't be the only metric you look at when researching a company. The DCF model is not a perfect stock valuation tool. Preferably you'd apply different cases and assumptions and see how they would impact the company's valuation. For instance, if the terminal value growth rate is adjusted slightly, it can dramatically alter the overall result. For Life360, we've compiled three further elements you should further research: Risks: Every company has them, and we've spotted 2 warning signs for Life360 you should know about. Future Earnings: How does 360's growth rate compare to its peers and the wider market? Dig deeper into the analyst consensus number for the upcoming years by interacting with our free analyst growth expectation chart. Other Solid Businesses: Low debt, high returns on equity and good past performance are fundamental to a strong business. Why not explore our interactive list of stocks with solid business fundamentals to see if there are other companies you may not have considered! PS. Simply Wall St updates its DCF calculation for every Australian stock every day, so if you want to find the intrinsic value of any other stock just search here. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store